ARCHIVES

Charges Against CC Probed; Most Found Invalid

This article is from The Cancer Letter archive.

Vol. 04 No. 13 | March 31, 1978

Download PDF Visit The Full Archive

Related Articles

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White

November 30, 1984

Seattle Cancer Care Alliance Marks its 10th Anniversary—January 2011

June 28, 2021

HHS Carcinogen Guidelines Draft

June 13, 1980

Breast Cancer Funding: Shalala Approves Agreement Over Disputed $14 Million

August 8, 1997

In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List

February 7, 1992